Our results showed that PTBP3 expression was increased in human RCC, and high PTBP3 expression was correlated with clinicopathological parameters such as lymph node metastasis, distant metastasis, TNM stage and poor five-year overall survival, and disease-free survival. Here, PTBP3 is linked to renal cell carcinoma.